People · Operator
Named in public records as an officer, director or promoter · active 2015–2024 · Healthtech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Diameter Health, Inc. | — | Healthtech | Series B | $30.7M | $418.3M | 2015 |
| Conduce, Inc./DE/ | — | Other | Seed | $3.0M | $14.1M | 2024 |
Eric Rosow at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Eric Rosow on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Matthew Storeygard | 2 | 6 |
| Mark Anderson | 1 | 20 |
| Kevin Ryan | 1 | 20 |
| Jeff DeFlavio | 1 | 5 |
| Word D. Peake | 1 | 5 |
| Word D. Peake III | 1 | 4 |
| Michael Cunningham | 1 | 3 |
| Sarah London | 1 | 3 |
| Richard Dumler | 1 | 3 |
| Matthew D. Storeygard | 1 | 2 |
| Najib Jai | 1 | 1 |
| John D'Amore | 1 | 1 |
| Kimberly Howland | 1 | 1 |
| Sarah D. London | 1 | 1 |
| Geoff Hogan | 1 | 1 |
| Harvard Pan | 1 | 1 |
| Mark D. Andersen | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.